000141996 001__ 141996
000141996 005__ 20240229105138.0
000141996 0247_ $$2doi$$a10.1111/nan.12479
000141996 0247_ $$2pmid$$apmid:29478280
000141996 0247_ $$2ISSN$$a0305-1846
000141996 0247_ $$2ISSN$$a1365-2990
000141996 0247_ $$2altmetric$$aaltmetric:33675972
000141996 037__ $$aDKFZ-2018-02226
000141996 041__ $$aeng
000141996 082__ $$a610
000141996 1001_ $$aCatanzaro, G.$$b0
000141996 245__ $$aThe miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
000141996 260__ $$aOxford [u.a.]$$bWiley-Blackwell$$c2018
000141996 3367_ $$2DRIVER$$aarticle
000141996 3367_ $$2DataCite$$aOutput Types/Journal article
000141996 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1549888948_1500
000141996 3367_ $$2BibTeX$$aARTICLE
000141996 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141996 3367_ $$00$$2EndNote$$aJournal Article
000141996 520__ $$aPaediatric low-grade gliomas (pLGGs) are a heterogeneous group of brain tumours associated with a high overall survival: however, they are prone to recur and supratentorial lesions are difficult to resect, being associated with high percentage of disease recurrence. Our aim was to shed light on the biology of pLGGs.We performed microRNA profiling on 45 fresh-frozen grade I tumour samples of various histological classes, resected from patients aged ≤16 years. We identified 93 microRNAs specifically dysregulated in tumours as compared to non-neoplastic brain tissue. Pathway analysis of the microRNAs signature revealed PI3K/AKT signalling as one of the centrally enriched oncogenic signalling. To date, activation of the PI3K/AKT pathway in pLGGs has been reported, although activation mechanisms have not been fully investigated yet.One of the most markedly down-regulated microRNAs in our supratentorial pLGGs cohort was miR-139-5p, whose targets include the gene encoding the PI3K's (phosphatidylinositol 3-kinase) catalytic unit, PIK3CA. We investigated the role of miR-139-5p in regulating PI3K/AKT signalling by the use of human cell cultures derived from supratentorial pLGGs. MiR-139-5p overexpression inhibited pLGG cell proliferation and decreased the phosphorylation of PI3K target AKT and phosphorylated-p70 S6 kinase (p-p70 S6K), a hallmark of PI3K/AKT/mTORC1 signalling activation. The effect of miR-139-5p was mediated by PI3K inhibition, as suggested by the decrease in proliferation and phosphorylation of AKT and p70 S6K after treatment with the direct PI3K inhibitor LY294002.These findings provide the first evidence that down-regulation of miR-139-5p in supratentorial pLGG drives cell proliferation by derepressing PI3K/AKT signalling.
000141996 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000141996 588__ $$aDataset connected to CrossRef, PubMed,
000141996 7001_ $$aBesharat, Z. M.$$b1
000141996 7001_ $$aMiele, E.$$b2
000141996 7001_ $$aChiacchiarini, M.$$b3
000141996 7001_ $$aPo, A.$$b4
000141996 7001_ $$aCarai, A.$$b5
000141996 7001_ $$aMarras, C. E.$$b6
000141996 7001_ $$aAntonelli, M.$$b7
000141996 7001_ $$aBadiali, M.$$b8
000141996 7001_ $$aRaso, A.$$b9
000141996 7001_ $$aMascelli, S.$$b10
000141996 7001_ $$0P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aSchrimpf, D.$$b11
000141996 7001_ $$0P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aStichel, D.$$b12
000141996 7001_ $$aTartaglia, M.$$b13
000141996 7001_ $$0P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aCapper, D.$$b14
000141996 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, A.$$b15
000141996 7001_ $$aGiangaspero, F.$$b16
000141996 7001_ $$aMastronuzzi, A.$$b17
000141996 7001_ $$aLocatelli, F.$$b18
000141996 7001_ $$00000-0001-7265-6429$$aFerretti, E.$$b19
000141996 773__ $$0PERI:(DE-600)2008293-9$$a10.1111/nan.12479$$gVol. 44, no. 7, p. 687 - 706$$n7$$p687 - 706$$tNeuropathology & applied neurobiology$$v44$$x0305-1846$$y2018
000141996 909CO $$ooai:inrepo02.dkfz.de:141996$$pVDB
000141996 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000141996 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000141996 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000141996 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000141996 9101_ $$0I:(DE-HGF)0$$60000-0001-7265-6429$$aExternal Institute$$b19$$kExtern
000141996 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000141996 9141_ $$y2018
000141996 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141996 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141996 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141996 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROPATH APPL NEURO : 2017
000141996 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000141996 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000141996 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141996 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000141996 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141996 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141996 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000141996 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000141996 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROPATH APPL NEURO : 2017
000141996 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x0
000141996 9201_ $$0I:(DE-He78)G380-20160331$$kG380$$lKKE Neuropathologie$$x1
000141996 980__ $$ajournal
000141996 980__ $$aVDB
000141996 980__ $$aI:(DE-He78)L201-20160331
000141996 980__ $$aI:(DE-He78)G380-20160331
000141996 980__ $$aUNRESTRICTED